CCL20- heparin sulfate interaction inhibitor (Sanford-Burnham Medical Research Institute/Free University of Berlin/UC San Diego/Shinshu University)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCCL20- heparin sulfate interaction inhibitor (Sanford-Burnham Medical Research Institute/Free University of Berlin/UC San Diego/Shinshu University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C motif chemokine 20 inhibitors
TargetsC-C motif chemokine 20
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanford-Burnham Medical Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlin Free UniversityShinshu UniversityUniversity Of California San Diego +[4] 
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A